9999999995-13-003204.txt : 20131107
9999999995-13-003204.hdr.sgml : 20131107
20131107001514
ACCESSION NUMBER: 9999999995-13-003204
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20131106
DATE AS OF CHANGE: 20131107
EFFECTIVENESS DATE: 20131106
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celsus Therapeutics Plc.
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-191880
FILM NUMBER: 131198269
BUSINESS ADDRESS:
STREET 1: 53 DAVIES STREET
CITY: LONDON
STATE: X0
ZIP: W1K 5JH
BUSINESS PHONE: 646-878-0804
MAIL ADDRESS:
STREET 1: C/O MARK COHEN, CHAIRMAN, PEARL COHEN
STREET 2: 1500 BROADWAY, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2013-11-06
10:00:00
0001541157
Celsus Therapeutics Plc.
333-191880